SPHINGOGLYCOLIPID ANALOGUES AS THERAPEUTIC AGENTS

This invention relates to sphingoglycolipid analogues of formula CN145: OH CN145 HO < - 0 n r 0 0 tail N Ci5115,4= compositions comprising these compounds, processes for preparing the compounds, and methods of treating or preventing diseases or conditions using the compounds, such as diseases or...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HERMANS, IAN FRANCIS, ANDERSON, REGAN JAMES, LARSEN, DAVID SAMUEL, HAYMAN, COLIN MALCOLM, COMPTON, BENJAMIN JASON, PAINTER, GAVIN FRANK
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY DERIVATIVES THEREOF HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SUGARS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This invention relates to sphingoglycolipid analogues of formula CN145: OH CN145 HO < - 0 n r 0 0 tail N Ci5115,4= compositions comprising these compounds, processes for preparing the compounds, and methods of treating or preventing diseases or conditions using the compounds, such as diseases or conditions relating to infection, atopic disorders, autoimmune disease, diabetes or cancer. Date Recue/Date Received 2020-06-05 La présente invention concerne des analogues de glycosphingolipide, des compositions comprenant ces composés, des procédés de préparation des composés, et des méthodes de traitement ou de prévention de maladies ou d'états faisant intervenir ces composés, tels que des maladies ou des états associés à une infection, des troubles atopiques, une maladie auto-immune, un diabète ou un cancer.